News|Podcasts|August 29, 2021
OncView™ Podcast: Updates in Therapies for Relapsed/Refractory Follicular Lymphoma
Author(s)Matthew Fowler, Javier L. Munoz, MD, MS, FACP
This special episode of “Oncology Peer Review On-The-Go” includes a discussion on relapsed/refractory follicular lymphoma with Javier Munoz, MD, MS, FACP.
Advertisement
As part of its OncView™ video series, CancerNetwork® spoke with Javier Munoz, MD, MS, FACP, from the Mayo Clinic in Phoenix, Arizona, about updates in therapies for relapsed/refractory (R/R) follicular lymphoma (FL).
In the video series, Javier Munoz, MD, MS, FACP, discussed the following:
Current Treatment Options for Relapsed/Refractory Follicular Lymphoma Factors in Choosing R/R FL Treatments Treatment Options for Third-Line R/R FL Use of Tazemetostat for R/R FL Changes in Sequencing of R/R FL Therapies
To watch more videos in CancerNetwork®’s OncView™ series, visit
Don’t forget to subscribe to the “Oncology Peer Review On-The-Go” podcast on Apple Podcasts, Spotify, or anywhere podcasts are available.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
Olomorasib Earns FDA Breakthrough Therapy in KRAS G12C+ Pancreatic Cancer
2
Epcoritamab Combo Shows Sustained Remissions in Follicular Lymphoma
3
FDA Approves RP1/Nivolumab for Progression on Anti–PD-1 Therapy in Melanoma
4
GLP-1 Receptor Agonists and Cancer: Renewed Momentum for Metabo-Oncology
5